Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

Gainers

• Orchard Therapeutics plc ORTX shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin Co., Ltd. to be acquired for $16.00 per ADS in cash plus an additional contingent value right of $1.00 per ADS, representing a total value of about $477.6 million.
• Meiwu Technology Company Limited WNW shares gained 62.3% to $0.1573 in pre-market trading after falling 4% on Wednesday.
• Molekule Group, Inc. MKUL shares rose 38.7% to $0.1595 in pre-market trading. Molekule Group shares fell 44% on Wednesday after the company and its subsidiary filed for Chapter 11 bankruptcy.
• Femasys Inc. FEMY rose 27.5% to $2.92 in pre-market trading after falling 8% on Wednesday.
• NKGen Biotech, Inc. NKGN rose 20.9% to $5.96 in pre-market trading. NKGen Biotech recently announced that it has closed its previously announced business combination with Graf Acquisition Corp. IV.
• Grom Social Enterprises, Inc. GROM shares climbed 18.8% to $2.08 in pre-market trading after gaining around 13% on Wednesday.
• Better Choice Company Inc. BTTR shares jumped 15.5% to $0.1848 in pre-market trading after gaining 12% on Wednesday.
• Momentus Inc. MNTS gained 14.6% to $1.26 in pre-market trading. Momentus announced closing of $4.0 million registered direct offering priced at-the-market under Nasdaq rules.
• China SXT Pharmaceuticals, Inc. SXTC shares rose 12.3% to $3.37 in pre-market trading. China SXT Pharmaceuticals reported a 1-for-25 reverse stock split.
• Tenaya Therapeutics, Inc. TNYA shares surged 10.7% to $2.38 in pre-market trading after falling over 8% on Wednesday.

Losers

• Cambium Networks Corporation CMBM fell 27.8% to $5.72 in pre-market trading after the company reported preliminary revenue for the third quarter. Cambium Networks said it sees revenues of $40 million to $45 million, versus prior forecast of $62 million to $70 million. The company also suspended its guidance for the full year 2023.
• SIGNA Sports United N.V. SSU fell 23.2% to $0.1090 in pre-market trading.
• MaxCyte, Inc. MXCT shares fell 21.4% to $2.57 in pre-market trading. MaxCyte said it sees third-quarter total revenue of $7.8 to 8.0 million, representing a decrease of 25% -27% versus the year-ago quarter. The company now expects total revenue of approximately $34 million to $36 million for the year.
• Neoleukin Therapeutics, Inc. NLTX fell 13.8% to $3.45 in pre-market trading. Neoleukin Therapeutics recently reported a 1-for-5 reverse stock split.
• Safety Shot, Inc. SHOT fell 12% to $1.10 in pre-market trading after declining more than 10% on Wednesday.
• Benson Hill, Inc. BHIL shares fell 10.5% to $0.2913 in pre-market trading after gaining 3% on Wednesday.
• Inspirato Incorporated ISPO fell 10.3% to $0.56 in pre-market trading. Inspirato said it has closed its $25 million senior secured convertible note issued by Inspirato to Capital One Ventures.
• Accolade Inc ACCD shares fell 9.2% to $8.85 in pre-market trading after the company reported second-quarter results. Accolade said it sees FY24 revenue of $410 million to $414 million.
• SeaStar Medical Holding Corporation SSU fell 8.8% to $0.5392 in pre-market trading. SeaStar Medical recently issued a regulatory update regarding selective cytopheretic device use in pediatric acute kidney injury under a humanitarian device exemption.
• Resources Connection, Inc. RGP fell 8.5% to $13.25 in pre-market after the company reported first-quarter financial results.

Now Read This: Dropbox, United States Steel And 2 Other Stocks Insiders Are Selling